InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Discover the detailed record of transactions filed by 진양곤. Director active across 1 company, notably HLB바이오스텝. Aggregated, 5 reports have been published. Regulator: DART (FSS). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
A declarant linked to HLB바이오스텝 (XKRX). The file contains 5 filings in total, and the sample of 5 recent filings covers the period from 2024-11-18 to 2026-06-10; the buy and sell amounts shown for that sample are both 0 EUR. The modal transaction nature is Other.